CLERA
DEAD

Serial Number

88573509

Owner

Empire Pharmaceutical Inc.

Attorney

Jeffrey D Larson

Filing Date

Aug 9, 2019

Add to watchlist:

No watchlists yet
View on USPTO

CLERA Trademark

Serial Number: 88573509

CLERA is a trademark filed by Empire Pharmaceutical Inc. on August 9, 2019. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Empire Pharmaceutical Inc. (3 trademarks)

Attn: Dr. Martin Unger
Toronto, Ontario M4S3H7 , CA

Entity Type: 03

Trademark Details

Filing Date

August 9, 2019

Registration Date

Not Registered

Published for Opposition

July 6, 2021

Goods & Services

Topical gel for the medical treatment of viral and bacterial infections in humans and animals

Filing History

ABANDONMENT NOTICE E-MAILED - INTER PARTES DECISION
Oct 22, 2021 MAB4
ABANDONMENT - AFTER INTER PARTES DECISION
Oct 21, 2021 ABN4
OPPOSITION TERMINATED NO. 999999
Oct 21, 2021 OP.T
OPPOSITION SUSTAINED NO. 999999
Oct 21, 2021 OP.S
OPPOSITION INSTITUTED NO. 999999
Jul 16, 2021 OP.I
EXTENSION OF TIME TO OPPOSE RECEIVED
Jul 13, 2021 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 6, 2021 NPUB
PUBLISHED FOR OPPOSITION
Jul 6, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 16, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 3, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 3, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 3, 2021 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Jun 2, 2021 ERSI
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Mar 15, 2021 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jul 24, 2020 RCSC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jan 24, 2020 GNS3
LETTER OF SUSPENSION E-MAILED
Jan 24, 2020 GNSL
SUSPENSION LETTER WRITTEN
Jan 24, 2020 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 24, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 24, 2020 CRFA
ASSIGNED TO LIE
Jan 23, 2020 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 13, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 16, 2019 GNRN
NON-FINAL ACTION E-MAILED
Nov 16, 2019 GNRT
NON-FINAL ACTION WRITTEN
Nov 16, 2019 CNRT
ASSIGNED TO EXAMINER
Nov 7, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 26, 2019 NWOS
NEW APPLICATION ENTERED
Aug 13, 2019 NWAP